Ameritas Investment Partners, Inc. Precision Biosciences Inc Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.15 - $3.34 $4,639 - $13,473	-4,034 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.66 - $8.7 $4,408 - $8,230	946 Added 30.63%	4,034 $34,000
Q4 2019 Feb 13, 2020	BUY	$6.32 - $19.66 $14,409 - $44,824	2,280 Added 282.18%	3,088 $43,000
Q2 2019 Aug 14, 2019	BUY	$11.88 - $16.94 $9,599 - $13,687	808 New	808 $11,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $1B
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.